TERREMOTO BIOSCIENCES
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
TERREMOTO BIOSCIENCES
Social Links:
Industry:
Biotechnology
Founded:
2021-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.terremotobio.com
Total Employee:
11+
Status:
Active
Total Funding:
250 M USD
Technology used in webpage:
SPF Amazon Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Amazon Virginia Region Amazon Route 53 Slack Zendesk
Similar Organizations
Aspen Neuroscience
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cormorant Capital
Cormorant Capital investment in Series B - Terremoto Biosciences
EcoR1 Capital
EcoR1 Capital investment in Series B - Terremoto Biosciences
Novo Holdings
Novo Holdings investment in Series B - Terremoto Biosciences
Third Rock Ventures
Third Rock Ventures investment in Series B - Terremoto Biosciences
OrbiMed
OrbiMed investment in Series B - Terremoto Biosciences
Third Rock Ventures
Third Rock Ventures investment in Series A - Terremoto Biosciences
OrbiMed
OrbiMed investment in Series A - Terremoto Biosciences
Key Employee Changes
Date | New article |
---|---|
2024-07-25 | Terremoto Biosciences Appoints Charles Baum, M.D., Ph.D., as Chief Executive Officer |
Official Site Inspections
http://www.terremotobio.com Semrush global rank: 6.95 M Semrush visits lastest month: 968
Unable to get host informations!!!

More informations about "Terremoto Biosciences"
About - Terremoto
Aug 14, 2025 At Terremoto, we are creating a seismic shift in the breadth of pursuable targets. Our ultimate goal? To deliver highly targeted, small molecule medicines with optimized clinical …See details»
Terremoto Biosciences - LinkedIn
Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy. The company leverages ...See details»
Terremoto Biosciences - Crunchbase Company Profile …
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.See details»
Terremoto Biosciences 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for Terremoto Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Terremoto - Overview, News & Similar companies | ZoomInfo.com
Jul 24, 2024 View Terremoto (www.terremotobio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Terremoto biosciences - Company info. interviews, news
Jan 12, 2024 Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy. The company leverages the …See details»
Terremoto Biosciences - VentureRadar
Equity Funding 02 Nov 2023 Terremoto Biosciences Closes $175 Million Series B Financing Source: terremotobio.com Venture-funding News Equity Funding 25 May 2022See details»
Terremoto Biosciences Inc. - BioCentury Company Profiles - BCIQ
Jan 10, 2025 Terremoto Biosciences Inc. Headquarters: San Francisco, CA, United States Website: https://terremotobio.com/ Year Founded: 2021 Status: Private BioCentury | Jan 10, …See details»
Terremoto | A seismic shift is coming to drug discovery and …
Jun 22, 2022 At Terremoto Biosciences, we are breaking new ground in the drug development landscape with a novel covalent chemistry approach. Our mission to develop life-changing …See details»
Terremoto Biosciences Company Overview, Contact Details
Nov 2, 2023 Third Rock invested into terremotobio.com $75M on May 1st '22. For instance, in May 2022, Terremoto Biosciences, a leading biotechnology company in California, raised …See details»
Terremoto Biosciences, Inc. - Drug pipelines, Patents, …
May 7, 2025 Explore Terremoto Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 9 news.See details»
Terremoto Biosciences - Products, Competitors, Financials, …
Jul 26, 2022 About Terremoto Biosciences Terremoto Biosciences focuses on drug discovery and development in the biotechnology industry. The company's main service is the …See details»
Terremoto Biosciences - Company Profile & Staff Directory
Terremoto Biosciences is a Biotechnology company located in 1700 Owens St, San Francisco, California 94158, US with 63 employees. Access Terremoto Biosciences's email format and …See details»
Terremoto Biosciences Closes $175 Million Series B Financing
Terremoto is supported by leading investors including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings and Cormorant Capital. More information is available at …See details»
Terremoto Biosciences (USA) Funding: $250M - Medical Startups
Jul 7, 2025 Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized...See details»
Terremoto Biosciences - Profiles & Contacts - Crunchbase
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.See details»
Careers - Terremoto
We are looking for additional scientists and industry leaders who are similarly driven to explore new scientific territory, as well as help shape the organization that Terremoto is today. Are you …See details»
Terremoto Biosciences Secures $175 Million Funding for …
Jul 24, 2024 Terremoto Biosciences, a pioneer in covalent drug discovery and development, has successfully raised an impressive $175 million in its latest funding round. This financing, …See details»
News - Terremoto
Jan 10, 2025 Terremoto Biosciences, a biotechnology company developing first- and best-in-class targeted, therapeutics, today announced the appointment of James Christensen, Ph.D., …See details»
Science - Terremoto
With our scientific approach, we have the potential to dramatically expand the universe of drug targets, as well as significantly improve upon existing medicines.See details»